APA (7th ed.) Citation

Dolce, D., Campana, S., Ravenni, N., Orioli, T., Camera, E., Fevola, C., . . . Taccetti, G. (2024). 101 Changes in airways sampling and microorganisms isolation after elexacaftor/tezacaftor/ivacaftor therapy in people with cystic fibrosis: A longitudinal study. Journal of Cystic Fibrosis, 23, S54. https://doi.org/10.1016/S1569-1993(24)00943-3

Chicago Style (17th ed.) Citation

Dolce, D., S. Campana, N. Ravenni, T. Orioli, E. Camera, C. Fevola, M. Francalanci, and G. Taccetti. "101 Changes in Airways Sampling and Microorganisms Isolation After Elexacaftor/tezacaftor/ivacaftor Therapy in People with Cystic Fibrosis: A Longitudinal Study." Journal of Cystic Fibrosis 23 (2024): S54. https://doi.org/10.1016/S1569-1993(24)00943-3.

MLA (9th ed.) Citation

Dolce, D., et al. "101 Changes in Airways Sampling and Microorganisms Isolation After Elexacaftor/tezacaftor/ivacaftor Therapy in People with Cystic Fibrosis: A Longitudinal Study." Journal of Cystic Fibrosis, vol. 23, 2024, p. S54, https://doi.org/10.1016/S1569-1993(24)00943-3.